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PMMAvertebroplastyinpatientswithmalignantvertebral
destruction of the thoracic and lumbar spine
PMMA Vertebroplastie bei Patienten mit malignen Destruktionen der
thorakalen und lumbalen Wirbelsäule
Abstract
Object:Patientswithosteolyticmetastasesfrequentlysufferfromserious
local and radicular pain. Pathophysiologically, local pain arises from
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treatment for patients with a limited life expectancy. Percutaneous
polymethylmethacrylate (PMMA) vertebroplasty is a new and easy
method of relieving patients' pain. In addition, it is both cost effective 1 Neurosurgical Clinic,
Universitätsklinikum, Justus- and safe. Pain is reduced immediately after treatment. Due to the re-
gained vertebral stability, early mobilization of the patients is possible. Liebig-Universität, Giessen,
Germany Methods: A total of 22 patients with osteolytic malignancies of the
thoracic and lumbar spine were treated with PMMA vertebroplasty. 2 Trauma Surgery,
Universitätsklinikum, Justus- Priortoandaftersurgery,thensixweeksandsixmonthsafterdischarge
Liebig-Universität, Giessen,
Germany
fromhospital,patientsansweredtheOswestryLowBackPainDisability
(OLBPD) Questionnaire for assessment of treatment-related change in
disability. Percutaneous vertebroplasty was performed in a total of 19
patients. In three patients with tumor related compression of nerve
roots an open neurolysis was performed followed by vertebroplasty.
Results:Atotalof86%ofpatientsreportedasignificantpainreduction.
Vertebroplasty was highly beneficial for patients with pain related to
localinstabilityofthespine,butlesssoinpatientswithadditionalnerve
rootcompression.ExtravasationofPMMAbeyondthevertebralmargins
was observed in 23% of the cases. No treatment-related clinical or
neurological complications were seen.
Conclusions: PMMA vertebroplasty is a useful and safe method of pain
reliefforpatientswithmalignantosteolyticdiseasesofthethoracicand
lumbar spine.
Zusammenfassung
Einleitung: Patienten mit osteolytischen Metastasen leiden häufig an
SchmerzenzweierQualitäten:denlokalenunddenradikulärenSchmerz.
Pathophysiologisch kann der lokale Schmerz auf die knöcherne Insta-
bilität zurückgeführt werden, wohingegen der radikuläre Schmerz aus
der Kompression der Nervenwurzeln durch lokales Tumorwachstum
resultiert.EineKausaltherapieosteolytischerMetastasen,dieAusdruck
der disseminierten Aussaat einer malignen Erkrankung sind, ist
schwierig. Die Resektion von Wirbeln in Kombination mit einer ventro-
dorsalen Stabilisation ist für diese Patienten mit sehr begrenzter Über-
lebenszeit ein komplexes Behandlungsverfahren. Die perkutane Poly-
methylmetacrylat (PMMA) Vertebroplastie ist eine neue und einfache
MethodedieSchmerzenderPatientenzuvermindern.Zusätzlichistsie
kostengünstig und komplikationsarm. Der Schmerz wird unmittelbar
nachAnwendunggelindert.Wegenderwiedergewonnenenknöchernen
Stabilität ist eine frühzeitige Mobilisation der Patienten möglich.
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Research Article OPEN ACCESSMethoden:Insgesamtwurden22PatientenmitosteolytischenMaligno-
menderthorakalenundlumbalenWirbelsäulemit derPMMA Vertebro-
plastiebehandelt.NachAufnahme,vorsowiesechsWochenundsechs
Monate nach Entlassung beantworteten die Patienten zur Beurteilung
von behandlungsbedingten Änderungen ihrer Beschwerden den Os-
westry Low Back Pain Disability (OLBPD) Fragebogen. Die perkutane
Vertebroplastie wurde bei 19 Patienten eingesetzt. Bei drei Patienten
mit tumorbedingter Kompression von Nervenwurzeln wurde die perku-
tane Vertebroplastie nach offener Neurolyse vorgenommen.
Ergebnisse:Insgesamt86%derPatientenberichtetenübereinesignifi-
kanteSchmerzreduktion.DieVertebroplastiehatteeinenhohenNutzen
bei Patienten mit Schmerzen, die durch eine lokale Instabilität hervor-
gerufen waren. Eine geringere Wirkung zeigte sich in Fällen mit zusätz-
licher Nervenwurzelkompression. Der Austritt von PMMA über die Wir-
belkörpergrenzen wurde bei 23% der Fälle beobachtet. Es traten keine
behandlungsbedingten neurologischen Komplikationen auf.
Schlussfolgerung: Die PMMA Vertebroplastie ist eine nützliche und si-
chere Methode zur Schmerzlinderung bei Patienten mit osteolytischen
Metastasen der thorakalen und lumbalen Wirbelsäule.
Introduction
Severe pain after compression fractures of the spine is
a common medical problem. Vertebral compression
fractures occur either due to mineral loss of the bone in
osteoporosis, or due to vertebral destruction in benign
or malignant tumors. Percutaneous vertebroplasty is a
method to augment bone and to relieve the pain by the
injection of polymethylmethacrylate into a collapsed ver-
tebral body [1]. In patients with malignancies, the infil-
tratingtumordestroystheintegrityofthevertebrae,which
is followed by vertebral collapse causing severe pain.
Regardless of the etiology, vertebral compression frac-
tures yield to disabling pain in all patients. Prior to the
introduction of percutaneous vertebroplasty, this pain
hasbeentreatedconservativelywithanalgesics,bedrest
andexternalbracing.However,thesetreatmentsprovided
only variable efficacy [2]. The minority of patients began
to get pain relief within a few days or weeks after their
fracture. The majority had severe and persistent pain for
weeks or months.
Surgery is rarely considered a therapy for patients with
metastatic bone infiltration. Vertebroplasty is useful for
the treatment of selected patients with spinal malignan-
cies. In general, the technique has been applied to pa-
tients with a limited life span, and those who are con-
sidered to be poor surgical candidates. Vertebroplasty
may be performed to provide pain reduction, spinal sta-
bilization, or both. Extensive osteolysis particularly in-
volving the posterior vertebral cortex may lead to a leak-
ageofthematerialusedforvertebroplastyintothespinal
canal. As a result spinal cord or nerve root compression
may occur. In contrast to benign compression fractures,
the treatment of neoplastic lesions often requires modi-
fication of the techniques used for vertebroplasty. Com-
binationofvertebroplastywithposttreatmentirradiation
is possible and useful.
The advantage of vertebroplasty for treatment of neo-
plastic disease was supported in a previous series. Weil
etal.[3]reportedaclearimprovementofpainin24(73%)
of 33 procedures in a series of patients treated for
metastaticlesionsbyvertebroplasty.Infivepatients(14%)
theyobservedminorcomplications,allrelatedtocement
extravasation. Three patients developed radicular pain.
In a follow up study on 37 patients "marked pain relief"
was noted in 22 (59%) cases. Extra-vertebral cement
leakage was detected by CT in 29 of the 40 treated ver-
tebrae. In almostall cases,the leakswere smalland had
no clinical relevance [4]. Comparing the treatment of
benignosteoporoticfractureswithvertebralmalignancies,
vertebroplasty has similar results with regards to pain
relief. However, complications were more frequent in
patients with malignancies. This study was conducted to
testthehypothesisthatthereductionofpainafterpercu-
taneous vertebroplasty is an immediate and long lasting
phenomenon that is highly beneficial for patients with
malignant osteolytic processes in the spine.
Methods
Between January and July 2002 patients with osteolytic
malignancies of the thoracic and lumbar spine without
neurological deficits were included into the study. The
main indication for treatment was pain.
Preoperatively, an intensive diagnostic workup was per-
formed in all patients including spinal MRI for detection
of tumor extension, localization, infiltration of the spinal
canal and paravertebral tissue; spinal CT of the affected
vertebrae for evaluation of paravertebral infiltration and
bony destructionand a conventionalx-ray of the affected
spinal region.
The degree of metastatic infiltration of the vertebral
bodies was quantified by the Tokuhashi scoring system
[5].
2/9 German Medical Science 2003, Vol. 1, ISSN 1612-3174
Winking et al.: PMMA vertebroplasty in patients with malignant vertebral ...Table 1: Five step quantification of the results of Oswestry Low Back Pain Disability Questionnaire
Life quality questionnaire
Forassessmentofchangesinqualityoflifeaftervertebro-
plasty all patients received the Oswestry Low Back Pain
Disability Questionnaire before, two days, six weeks and
six months after vertebroplasty [6]. This questionnaire is
divided into ten sections assessing back pain related
limitations of various activities of the daily life. Each sec-
tion contains six statements. The patient marks the one
statement in each section which describes his limitation
most accurately. Each section is scored on a 0-5 scale,
5 representing the greatest disability. The scores for all
sections added together, give a possible score of 50. If
a section is not completed because it is inapplicable, the
finalscoreisadjustedtoobtainapercentage.Thevalidity
andreliabilityofthequestionnairewasproofedbyseveral
studies [7], [8], [9]. A 5-step disability score was used to
group the percentage results (Table 1). Results from the
pre- and post-treatment questionnaire were compared.
Pain assessment
Twoadditionalpainscaleswereused.Thevisualanalogue
scale was used to estimate the patients' pain perception
priorto,twodays,sixweeksandhalfayearaftervertebro-
plasty. This scale with a range of 0-10 is a standard
method in pain analysis. 0 stands for no pain, 10 for in-
tolerable pain.
All patients receiving local anesthesia for vertebroplasty
wereadditionallyaskedabouttheircomfortlevelsduring
the operation procedure. A five step scale was used im-
mediately after treatment. The scale was defined as fol-
lows:
1. no problems
2. short lived and well tolerable pain
3. moderate pain
4. distinct pain during the procedure
5. intolerable pain.
Patients, who received general anesthesia for surgical
neurolysisfollowedbyvertebroplastywereexcludedfrom
this part of analysis.
Analgesic medication
Preoperatively most patients received an analgesic
combinationregime for pain treatment.Changes in anal-
gesia after vertebroplasty were assessed using a 5 step
classification (Table 2).
Treatment procedure
Bilateral vertebroplasty was performed in the operating
room using fluoroscopy. All patients, except those with
segmental pain related to tumor compression of nerve
roots,weretreatedunderlocalanesthesiawithXandicain
1%. Midazolam was given as mild sedation, if needed.
Patients with additional radicular pain were treated in
general anesthesia.
During positioning on the operating table, attention was
paid to upholster the kyphotic or lordotic spinal malalign-
ment.
Needle placement for percutaneous vertebroplasty was
performed using standard fluoroscopy (Siremobil 2000,
Siemens Erlangen, Germany).
A commercially available kit was used for vertebroplasty
(Stryker Coorporation, Jersey City, NJ, U.S.A.). The kit
contains needles, 1 and 3 cc syringes for injection, and
a vacuum-assisted cement mixing device, as well as a
package of Howmedica Surgical Simplex P™ cement.
Thepedicleswereidentifiedunderanterior-posterior(AP),
bilateral oblique and lateral view. An approach directly
lateral of the pedicles was used to minimize the risk of
spinal cord or nerve root injury. Bilaterally, the vertebral
bodywaspuncturedwitha13gaugeneedle.Afterfluoro-
scopic control with contrast medium (Solutrast, 2cc, Byk
Gulden, Germany) PMMA was injected into the damaged
vertebrae. In a post treatment CT-scan the access for
vertebral body puncture is shown (Figure 1).
Three hours after the vertebroplasty procedure, patients
were allowed to get up and walk without additional exter-
nal orthesis.
Data analysis
Mean +/-SEM values were calculated and statistical
analysis was performed using students t-test and Wil-
coxon test for paired values. Statistical significance was
accepted for p<0.05.
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Figure 1: Computed tomography of vertebral body L1 after vertebroplasty.
Arrows mark the puncture canal for PMMA injection. The white staining marks the PMMA inside the vertebral body. Small picture
on the right: post-treatment X-ray
Results
Twenty-two patients with secondary malignancies of the
thoracic and lumbar vertebral column were examined.
The mean age of the patients was 59.5 ± 1.9 years. The
maletofemaleratiowas2.1:1.Thediagnosisofvertebral
metastasiswasmadeafterbackpainpromptedaradiolo-
gical diagnostic in all patients.
Back pain was the sole indication for treatment in this
study. No patient showed a tumor related neurological
deficit. Mostly, terrible pain related to body movement
limited the mobility of the patients. Three patients were
immobilizedcontinuouslyduetopainateverymovement
of their body. Further five patients rested mainly in bed
because of unforeseeable pain attacks during walking.
Twelvepatientswerecategorizedintothegroupofsevere
disability, whereas two patients showed only moderate
disability.
In two cases of pulmonary cancer and in one of prostate
cancer additional radicular pain was observed besides
back pain. These three patients were grouped in the bed
rest group (Figure 4, Table 1). MRI in all three patients
showed local nerve root compression by the tumor in
combination with osteolytic destruction of two vertebral
bodiesandpedicles.Thesethreepatientswithinfiltration
of the neighboring vertebrae were first treated by hemil-
aminectomy and local tumor removal for surgical neuro-
lysis. Vertebroplasty followed subsequently as a second
step during the same general anesthesia.
Histology
The primary tumor was histologically confirmed in all pa-
tients. Primary tumor sites were lungs, prostate and
breasts in 50%, 27% and 18% of patients, respectively.
One patient (5%) had a spinal compression due to a
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Note that 15 of 26 (58 %) of affected vertebrae are located in the lower thoracic and upper lumbar spine (Th 8-L1). None of the
vertebrae were located in the cervical spine.
plasmocytoma in a vertebrae. Most of the patients re-
ceivedstandardtreatmentfortheprimarytumorincluding
surgery and combined radio-chemotherapy prior to ver-
tebroplasty.
Localization
Four patients showed an infiltration of more than one
vertebral body. In two of them the adjacent to L 4 and 5
and in one case the vertebral bodies of TH 10 and 11
were affected. One patient showed an infiltration of mul-
tiple vertebral bodies. Clinical symptoms were apparent
for a metastasis in vertebral body of L 3. He was treated
only in the symptomatic localization.
Middle and lower thoracic vertebral column was the pre-
dominant localization of metastases. A lower number of
cases were observed in lumbar spine (Figure 2).
Pain assessment
According to the visual analog scale, the median pain
value preoperatively was 6.4 (2.3 to 9.1). Two days after
treatment, the visual analogue scale showed a general
reduction of pain. Median pain value decreased signifi-
cantly to 2.1 (0.8 to 4.6; p<0.01). Excluding the three
patients from the analysis that were treated by combina-
tion of hemilaminectomy and vertebroplasty, pain im-
proved to 1.5 (0.8 to 2.9; p<0.01) (Figure 3).
Immediately after vertebroplasty the patients treated
under local anesthesia were asked for their discomfort
during the procedure. The subjective judgment of the
patients showed no major problems. Using the five step
division for their "comfort" during vertebroplasty, the
medianstrainon the wholetreatmentincludingposition-
ing of the patient, puncture procedure and duration was
2 (range 1 to 3).
Preoperative analgesic drug usage was reduced during
24 hours after vertebroplasty. Three patients expressing
minor local pain preoperatively did not receive any medi-
cation at 24 hours after vertebroplasty. One of these pa-
tients remained free of analgesic drugs at six months
after vertebroplasty. Especially in patients with opioide
andmorphinemedicationdrugreductionwasperformed
carefully. At six weeks after operation the number of pa-
tients with class 3 and 4 medication was significantly re-
duced. No patient receiving class 4 drugs preoperatively
became drugfree. But they were grouped into lower drug
classes or were treated with reduced amounts of their
prior medication. These circumstances explain the num-
ber of NSAID and class 2 drugs treated patients already
after six months.
Additional treatment with benzodiazepine for muscle re-
laxation or neuroleptics was also reduced during six
weeks after operation and remained on a lower postop-
erative level.
OLBPD-Questionnaire
Themostimportantpointofthestudyandmainobjective
of the treatment was the reduction of osteolysis related
vertebral pain and the improvement of the patients'
quality of life. Quality of life was assessed pre- and post-
operativelybytheOLBPD-questionnaire.Beforecomplet-
ing the questionnaire two days after vertebroplasty the
patients had to do physical exercises like walking, climb-
ing stairs, knee-bend and bending over. As shown in Fig-
ure 4, all patients reported a pain relief. The average im-
provement was 1.7 ± 0.1 steps of the disability score
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(* for P < 0.001, ** for P < 0.001, n = 22)
Figure 4: The Oswestry Low Back Pain Disability Questionnaire.
Disability before and after vertebroplasty. All patients improved significantly after the procedure.
6/9 German Medical Science 2003, Vol. 1, ISSN 1612-3174
Winking et al.: PMMA vertebroplasty in patients with malignant vertebral ...(p<0.01). Treatment in the subgroup of patients with
local and radicular pain was less successful. Local pain
improved well. However, residual radicular pain resulted
in a minor improvement. Overall, Wilcoxon statistical
analysis of the relief of disability showed a highly signifi-
cantimprovementaftervertebroplasty(p<0.01).Although
a slight worsening occured during the six month postop-
erative time, quality of life persisted on a significantly
higher level than preoperatively.
Complications
ExtravasationofPMMAoutsidethevertebralmarginswas
defined as minor treatment complication. This complica-
tion was observed in five patients (23%). No patient de-
veloped any clinical or neurological symptoms. Further
treatment related complication did not occur. Periopera-
tive mortality was 0%.
Discussion
Summary of findings
In this study a total of 22 patients with back pain due to
osteolytic metastasis of various primary tumors were
treatedwithvertebroplasty.Overallasignificantreduction
of pain could be achieved. The patients tolerated the
procedure well. Although the total amount of analgesic
drugswasnotreducedsignificantly,severalpatientswere
treatedsatisfactorilywithreducedamountsofanalgesics
or with drugs of lower classes. The OLBPD-assessment
revealed a significant reduction of pain leading to im-
proved daily life activity and quality of life within two days
after vertebroplasty. During the following six months
qualityoflifediminishedslowlybutremainedsignificantly
improved.
Patients were ambulatory within three hours after the
procedure. No new neurological deficits were observed
and the mortality of the procedure was 0%. Therefore,
the procedure is considered to be safe. The results on
painreductionandimprovedqualityoflifeincombination
with reduced pain medication indicate the benefit of
vertebroplasty in patients with spinal metastases.
Treatment options in patients with
osteolytic metastasis
Osteolytic metastases and myeloma are the most fre-
quent malignant osteolytic lesions of the spine. Severe
back pain and disability represent the major symptoms
inaffectedpatients.Mechanicalpainisthepredominant
type of pain in patients with osteolytic metastasis.
Therapeutic management depends on the number of af-
fected vertebrae, the spinal level and the osteolytic loca-
tion of the tumor within the vertebra. Epidural extension
of tumor tissue in the spinal canal together with the
neurological signs determines the therapeutic regimen.
In general, the baseline condition of the patient sets the
limitations of the therapeutic extend. The timing of the
treatment is primarily determined by the severity of pain
and disability.
Radiation therapy gives partial or complete relief of the
pain in more than 90% of patients [10]. However, this
analgesic effect is not obtained until 10-20 days after
the procedure. Strengthening of osteolytic vertebra after
irradiationisminimalwithahighremainingriskofpainful
vertebral collapse [10].
Vertebrectomy and surgical reinforcement of osteolytic
vertebralbodiesisnotpracticalinmostpatientsbecause
ofthemultifocalnatureofthedisease.Therefore,minimal
invasive methods with the aim of pain release combined
withastabilizingcompoundwillbethemethodofchoice.
The immediate analgesic effect of vertebroplasty can be
explained by a so called "in situ immobilization" of verte-
bral body fracture. Pathophysiologically, the cement is
inserted into the bone and stabilizes the bone immedi-
ately. In addition, the polymerisation heat may destroy
pain fibers in the bone itself.
Indications for vertebroplasty
Clinical appearance
The best results are seen in patients who complain of a
severe, focal, and mechanical back pain, requiring bed
rest and major analgesic drugs, related to a neoplastic
vertebral collapse without epidural involvement [11]. In
a study on 37 patients with osteolytic metastases pain
decreasedin97.3%ofpatients[12].Inatwoyearsfollow-
up narcotic and analgesic drug usage decreased by 63%
[13].Inourstudyfocalpainduringmovementrepresented
the best indication for vertebroplasty.
The indications for vertebroplasty and open surgery are
different.Decompressionofspinalcanalandnerveroots
are main goals of surgical therapy. A combination of the
twomethodsmaybeindicatedifvertebroplastyfacilitates
surgery. Vertebroplasty provides an anterior stabilization
of the vertebral column that may avoid an anterior surgi-
calapproach.Ifnecessaryposteriorsurgicalstabilization
can be performed with smaller orthesis following dorsal
decompression.
Radiological appearance
The vertebral collapse must not be complete. In case of
an osteolysis with a high risk of vertebral collapse, it is
indicated to perform vertebroplasty already in asympto-
maticmetastaticvertebralbodylesionsinordertoprevent
the collapse [11]. The amount of cement inserted does
not correlate with the reduction of pain [4]. There is no
reason for a complete filling of the lesion. It is better to
avoid a leakage of cement with the risk of cord compres-
sion, especially in extensive cortical osteolytic lesions.
The amount of PMMA used in this study ranged between
3 and 6 ml.
Vertebroplasty and adjacent therapies
Radiotherapy should be performed after vertebroplasty.
Radiationtherapydoesnotinterferewiththemechanical
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ments the analgesic effect of vertebroplasty.
Vertebroplasty seems to have an antitumoral effect. This
can explain the low number of cases of local recurrence
evenifvertebroplastyisnotcompletedbyirradiation.The
antitumoral effect may be explained by the local toxicity
of PMMA and the heat of polymerisation and ischemia
induced by the injection of cement in a limited tumoral
tissue volume [15], [16], [3].
Complications of vertebroplasty
Ingeneral,morecomplicationsarereportedaftervertebro-
plastyofmalignantlesionsthanofosteoporoticfractures
[3]. Most complications are due to leakage of cement, in
casesofcorticalosteolysis.Theuseofarelativelyviscous
cement mixture may prevent leakage in this situation
[17], [4], [18]. Needle placement should be guided by
theparticularanatomyofeachspecificlesion.Ingeneral,
anteriorneedleplacementisdesirablesothatthecement
is injected as far from the spinal canal as possible. Mul-
tiple needle placements and separate cement injections
may be necessary to fill the vertebral body adequately
without compromising of the spinal canal or the neural
foramen. The goal of cement injection is to provide ad-
equatesupportfortheanteriorcolumn.Thecomplication
rate for vertebroplasty in malignant spinal lesions is 10%
[11]. Three types of acute symptoms can be observed:
increased pain not associated with cement leak, radicu-
lopathy, and spinal cord compression. Radiculopathy is
the major complication of vertebroplasty with a risk of
4% [11]. The thoracic and lumbar transpedicular ap-
proachofthevertebralbodyavoidsleaksintotheexternal
part of the neural foramina along the needle track and
the risk of radiculopathy [11]. In osteolytic vertebral col-
lapse and narrow pedicles of thoracic vertebral column,
anapproachimmediatelylateraltothepediclewillprovide
additional safety in order to avoid opening of the spinal
canal or damaging of a nerve root. Vertebroplasty under
local anesthesia should be considered for the treatment
of patients with osteolytic vertebral collapse [19], [18].
Awakepatientsallowtheclinicaldetectionofneurological
symptoms during the injection. In our study under local
anesthesia, patients tolerated the procedure well and
reported only little pain. None of the patients canceled
the procedures due to intolerable pain.
Conclusions
Percutaneousvertebroplastydevelopedby Galibert et al.
[1] as treatment option for patients with malignant de-
struction of the thoracic and lumbar vertebral column
provides fast pain relief by in situ immobilization of des-
troyed vertebra. Painless mobilization immediately after
treatment restores the patients' quality of life and allows
early discharge from the hospital.
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